Cuprina Holdings (Cayman) vs Profusa
CUPR and PFSA side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CUPR and PFSA compare
Cuprina Holdings (Cayman) scores higher on the StockData Score (3 against 0 for Profusa), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CUPR | PFSA |
|---|---|---|
| Size and price | ||
| Market cap | – | $53.7K |
| Share price | $1.68 | $0.406 |
| Change, 1 year | −72.4% | −100.0% |
| Beta (5Y) | −0.14 | 3.11 |
| Employees | 10 | – |
| StockData Score | ||
| Total score | 3 (better) | 0 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 2 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 3.3% | – |
| Profitability | ||
| Gross margin | −1.3% | – |
| Operating margin | −9680% | – |
| Net margin | −9367% | – |
| FCF margin | −18423% | – |
| Return on equity | −1569% | – |
| Financial health | ||
| Debt / equity | 0.03 | – |
| Interest coverage | −328.0× | −136.6× (better) |
| Current ratio | 2.35 (better) | 0.03 |
| Altman Z-score | – | −364.70 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.00% | 25.3% |
| Insider net buying, 12 months | – | −$116K |
Go deeper
- CUPR stock overview
- CUPR income statement
- CUPR valuation and score
- PFSA stock overview
- PFSA income statement
- PFSA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.